期刊文献+

过继免疫治疗对手术后肺癌患者外周血免疫细胞表型影响的研究 被引量:1

Effects of CIK on the Lymphocytes Immunophenotype in Patients with Lung Cancer
下载PDF
导出
摘要 目的:探讨C IK过继免疫治疗对手术后肺癌患者免疫功能的影响。方法:采用流式细胞术检测40例肺癌患者外周血T细胞、B细胞和NK细胞表型。结果:肺癌患者CD3+、CD4+、CD4/CD8比值明显低于对照组并呈显著性差异,而CD8+细胞高于对照组(P<0.01)。经C IK治疗后CD3+、CD4+、CD3-/CD16+56+细胞和CD4/CD8比值都升高,其中CD4+、CD3-/CD16+56+细胞与治疗前比较呈显著性差异(P<0.05),而CD8+细胞与治疗前比较降低(P<0.05);CD19在治疗后稍有增高趋势,但无显著性差异。结论:C IK过继免疫治疗对肺癌患者免疫功能的恢复具有促进作用。 Objective: To investigate the immunophenotype of patients with lung cancer treated with CIK. Methods: The T cell and B cell subsets and NK cells in peripheral blood from patients with lung cancer ( n = 20) were detected with flow cytometry. Results: The CD3 ^+, CD4^ + and CD4/CD8from pre - operation patients with breast cancer were significantly lower than that of the control ( P 〈 0. 01 ). Compared with the control group, the CD8^ + cells from patients with lung cancer were increased (P 〈0, 01 ). The CD3^ + , CD4 ^+, CD3^ -/CD16 + 56 + cells and CD4/CD8 from post -operation patients treated with CIK were increased. Compared with pre- operation, the differences of CD4^ +, CD3^ -/CD16 + 56 + ceils were significant ( P 〈 0.05) and the CD8 + ceils were decreased ( P 〈 0.05 ) , Conclusion: The immunological function of patients with lung cancer is decreased and con be enhanced by CIK adoptive immunotherapy.
出处 《中国妇幼保健》 CAS 北大核心 2005年第22期2979-2981,共3页 Maternal and Child Health Care of China
基金 吉林省科技厅重点项目(编号:20050402-3) 吉林省科技厅重点项目(编号:20040401-5) 吉林省科技厅国际合作项目(编号:20040707-2) 2004年长春市科技局计划项目(编号:2004218) 高等学校博士学科点专项科研基金(编号:20020183017)
关键词 过继免疫治疗 CIK 肺癌 免疫表型 Adoptive immunotherapy CIK Lung cancer Immunophenotype
  • 相关文献

参考文献8

  • 1Sheu BC, Hsu SM, Ho HN et al. Reversed CD4/CD8 ratios of tumor infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Cancer, 1999, 86 (8): 1537.
  • 2Robinson E , Segal R, Struminger L et al. Lymphocyte Subpopulllations in Patients with Multiple Primary Tumor. Cancer, 1999, 85:2073.
  • 3Mark J. S, Kevin Y. R. T, Shayna E. A. S et al. Defferential Tumor Surveillance by Natural Killer (NK) and NKT Cells. J of Experimental Medicine, 2000, 191 (4): 661.
  • 4Brittenden J, Heys SD, Ross J et al. Natural Killer Cell and Cancer. Cancer, 1996, 77 (7): 1226.
  • 5Schmidt - Wolf GD, Negrin RS, Schmidt - Wolf IG. Activated T cells and cytokine - induced CD3 + CD56 + killer cells. Ann Hematol,1997, 74 (2): 51.
  • 6Hernberg W, Muhonen T, Turunen JP et al. The CD4/CD8 ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy. J of Clinical Oncology, 1996, 14 (5): 1690.
  • 7Gerald C. O'sillivan, Anne R et al. Regional Immunosuppression in Esophageal Squamous Cancer. J of Immunology, 1996, 157:4717.
  • 8Schmidt - Wolf GH, Negrin R S, Kiem H P et al. Use of SCID mouse/human lymphoma model to evaluate cytokine induced killer cells with potent anti -tumor cell activity. J Exp Med, 1991, 174:139.

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部